CymaBay Therapeutics Inc (USD)
CBAY
Overview
Key Information
Legal Documents
Financials
Overview
| Sector | Healthcare |
| Industry | - |
| Day Range | 6.28 | 6.67 |
| 52-Wk Range | - | - |
| Last Close | 6.51 |
| Mkt Cap (m) | 448.45 |
| Dividend yield | - |
| ISIN | US23257D1037 |
| Volume | 985,300.00 |
| Exchange Venue | NAS |
Company Profile
CymaBay Therapeutics Inc is an American biotechnology enterprise. Its product candidates include Arhalofenate, MBX-8025, and MBX-2982, which are meant to combat serious metabolic diseases.
Key Information
| Price/Earning | - |
| Price/Book | 2.71 |
| Price/Sales | - |
| P/CF | - |
| Rev Growth (3 year avg) | 0.00 |
| EPS Growth (3 year avg) | - |
| Operating Margin % | - |
| Net Margin % | - |
| Return on Equity | -57.63 |
| Debt/Equity | 0.01 |
Documents
Prospectus
| en 14/07/2020 |
Annual Report
| en 31/12/2019 |
Please refer to the below issuer website for further documents.
Financials
Income Statement
| USD | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
| Revenue (m) | 0.00 | 0.00 | 0.00 | 10.00 | 0.00 | 0.00 |
| Operating Income (m) | -24.01 | -25.90 | -25.59 | -21.33 | -72.51 | -103.08 |
| Net Income (m) | -31.92 | -15.53 | -26.67 | -27.56 | -72.55 | -102.81 |
| Basic EPS | -2.65 | -0.82 | -1.14 | -0.79 | -1.25 | -1.53 |
| Avg. Diluted Shares Outstanding (m) | 12.05 | 18.92 | 23.45 | 34.90 | 57.84 | 67.03 |
Balance Sheet
| USD | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
| Current Assets (m) | 37.23 | 42.79 | 18.53 | 103.54 | 181.56 | 202.92 |
| Non Current Assets (m) | 0.25 | 0.29 | 0.83 | 0.70 | 5.19 | 2.80 |
| Total Assets (m) | 37.47 | 43.08 | 19.36 | 104.25 | 186.75 | 205.73 |
| Current Liabilities (m) | 20.46 | 6.15 | 9.31 | 16.31 | 14.42 | 17.64 |
| Total Liabilities (m) | - | - | - | - | - | - |
| Total Equity (m) | 13.85 | 28.12 | 3.94 | 84.95 | 170.42 | 186.35 |
Cash Flows
| USD | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
| Operating Cash Flows (m) | -21.11 | -23.32 | -23.35 | -19.63 | -54.94 | -97.91 |
| Capital Expenditure (m) | -0.10 | - | -0.04 | -0.03 | -0.53 | -0.32 |
Figures are quoted in USD unless stated otherwise
-
No change
$
6.51
Last Price
© 2019 MeDirect Bank (Malta) plc. All rights reserved.